Otros idiomas Cochlear Limited

Acciones

COH

AU000000COH5

Mercado cerrado - Australian S.E. Otros sitios de cotización 08:10:44 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
320,8 ^AUD	+0,24 %		+1,62 %	+7,40 %

22/04	Cochlear Limited anuncia cambios en la Secretaría de la Compañía	CI
19/04	Cochlear Limited obtiene la autorización de la FDA para rebajar la edad del sistema Osia a los 5 años	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Cochlear Limited Announces Company Secretary Changes	22/04
Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old	19/04
ACCC will not oppose revised Cochlear, Oticon Medical transaction	04/04
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	04/04
Miners, healthcare firms push Australia stocks higher	25/03
Sensorion : résultats d'une étude dans la perte auditive	11/03
Cochlear's Revenue Soars on Sales Growth	19/02
Australian Shares Flat as Mining, Financials Rally Offset Other Sectors' Losses	19/02
Cochlear Shares Slip 2%; Expects 26% Rise in Full Year Net Profit After Increase in H1 FY24 Profit, Revenue	19/02
Cochlear Posts Rise in H1 FY24 Profit, Revenue	18/02
Correction: --Cochlear Reports Half Year FY24 Revenue Up 24% to AU$1.1 Billion; EPS of AU$2.913	18/02
Cochlear Reports Half Year FY24 Revenue Up Down 24% to AU$1.1 Billion; EPS of AU$2.913	18/02
Tranche Update on Cochlear Limited's Equity Buyback Plan announced on February 15, 2023.	18/02
Cochlear Limited Reports Earnings Results for the Half Year Ended December 31, 2023	18/02
Cyclopharm Appoints CFO; Shares Rise 3%	12/02
Australia shares slip as biotech firm CSL slumps on failed drug trial (Feb 12)	12/02
Australian shares post first weekly fall in three as rate-hike bets back in focus	09/02
Cochlear Upgrades Fiscal 2024 Profit Guidance; Shares Up 5%	08/02
Sensorion: fin du recrutement pour l'essai clinique de Sens-401	01/02
Australia's CSL tanks as Novo Nordisk's kidney trial success stokes competition concerns	12/10/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Cochlear Limited

Acciones

COH

AU000000COH5

Otros idiomas

Filtros